Lv61
3180 积分 2023-07-25 加入
The antibody–drug conjugate landscape
13天前
已完结
P1.06B.16 HER3 Expression Across Genomic Subsets of NSCLC
14天前
已完结
Antibody-drug conjugates: A promising novel therapeutic approach in lung cancer
14天前
已完结
A validated surrogate analyte UPLC–MS/MS assay for quantitation of TUDCA, TCDCA, UDCA and CDCA in rat plasma: Application in a pharmacokinetic study of cultured bear bile powder
2个月前
已完结
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
2个月前
已完结
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
2个月前
已完结
c-Myc-Targeting PROTAC Based on a TNA-DNA Bivalent Binder for Combination Therapy of Triple-Negative Breast Cancer
5个月前
已完结
Evolving Strategies for Target Selection for Antibody-Drug Conjugates
6个月前
已完结
Immunotherapy plus chemoradiotherapy in cervical cancer management
6个月前
已完结
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
7个月前
已完结
皖公网安备34019202002308
